Caribou Biosciences Inc

CRBUNASDAQ · USD
1.35USD+0.05 (+3.85%)
335

Caribou Biosciences Inc (CRBU) Straddle

No qualifying straddle setups were found for CRBU in the prior session.

Read more

Trading a CRBU straddle lets you take a pure volatility position on Caribou Biosciences Inc without committing to a direction. Caribou Biosciences Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate CRBU straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on CRBU profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Caribou Biosciences Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the CRBU straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors.

It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the CRBU straddle is the cleanest expression of that view. Our scanner prices every CRBU straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a CRBU straddle into a catalyst or short a CRBU straddle to harvest decay, the options straddle setups that matter are all in one place.

No illustrative rows to display.

As of September 21, 2026

Find the right straddle before volatility moves

Track CRBU straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial